Since elevated expression of IGF-1R increases the risk of breast, colon, prostate, and lung cancer, and blocking IGF-1R decreases cell growth and tumor formation, IGF-1R is increasingly recognized by the medical community as a relevant target for investigation in cancer research [10]. Here, IGF1R is linked to lung carcinoma.